A Phase II Study of the Combination Chemotherapy Consisted of Rituximab and THP-COP Regimen as First-Line Treatment for Patients with Diffuse Large B-Cell Lymphoma.

被引：0
|
作者：
Tsurumi, Hisashi [1 ]
Goto, Naoe [2 ]
Hara, Takeshi [1 ]
Kasahara, Senji [1 ]
Kanemura, Nobuhiro [1 ]
Kitagawa, Junichi [1 ]
Yoshikawa, Takeshi [3 ]
Yamada, Toshiki [1 ]
Sawada, Michio [1 ]
Takahashi, Takeshi [3 ]
Takami, Tsuyoshi [2 ]
Moriwaki, Hisataka [1 ]
机构：
[1] Gifu Univ, Grad Sch Med, Dept Internal Med 1, Gifu, Japan
[2] Gifu Univ, Grad Sch Med, Dept Immunopathol, Gifu, Japan
[3] Gifu Municipal Hosp, Div Hematol, Gifu, Japan
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1231 / 1231
页数：1
相关论文
共 50 条
  • [31] Three-Year Follow-up on Safety and Effectiveness of Rituximab Plus Chemotherapy As First-Line Treatment of Diffuse Large B-Cell Lymphoma
    Feng, Jifeng
    Wu, Jianqiu
    Song, Yongping
    Su, Liping
    Zhang, Mingzhi
    Li, Wei
    Hu, Yu
    Zhang, Xiaohong
    Gao, Yuhuan
    Niu, Zuoxing
    Feng, Ru
    Wang, Wei
    Peng, Jiewen
    Li, Xiaolin
    Ouyang, Xuenong
    Wu, Changping
    Zhang, Weijing
    Zeng, Yun
    Xiao, Zhen
    Liang, Yingmin
    Zhuang, Yongzhi
    Wang, Jishi
    Sun, Zimin
    Bai, Hai
    Cui, Tongjian
    BLOOD, 2017, 130
  • [32] Rituximab-bendamustine for first-line treatment of older patients with diffuse large B cell lymphoma: a multicenter analysis
    Zeremski, V.
    Kahl, C.
    Mohren, M.
    Jentsch-Ullrich, K.
    Eberhardt, J.
    Fischer, T.
    Schalk, E.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 45 - 46
  • [33] Diffuse large B cell lymphoma: first-line and salvage treatment
    Held, Gerhard
    Glass, Bertram
    ONKOLOGE, 2019, 25 (10): : 880 - 891
  • [34] Rituximab biosimilar RTXM83 versus reference rituximab in combination with CHOP as first-line treatment for diffuse large B-cell lymphoma: a randomized, double-blind study
    Candelaria, Myrna
    Gonzalez, Derlis E.
    Delamain, Marcia Torresan
    Bar, Daniel Oscar
    Beniwal, Surender Kumar
    Dasappa, Lokanatha
    Flores, David Hugo
    Querol, John
    Guan, Toh See
    Lipatov, Oleg Nikolaevich
    Volodicheva, Elena Mikhailovna
    Patel, Moosa
    Nodehi, Sayyed Reza Safaee
    Fogliatto, Laura
    Paravisini, Alexandra
    Perez Diaz, Luis
    Bhatt, N.
    Bhattacharyya, S.
    Mukhopadhyay, A.
    Salvatierra, A.
    Radhakrishnan, V.
    Bhurani, D.
    Jasuja, S.
    Kowalyszyn, R. D.
    da Silva Araujo, S. Shusterschitz
    Syafei, S.
    Caffaro, J.
    De Stefano, G.
    Garcia, J. J.
    Ciliao Munhoz, E.
    Bermudez, C.
    Gin, G. Gin
    Raman, R.
    Villegas, E. M.
    Martinez-Lapus, F. G. P.
    Molina Barrios, G. R.
    Tiangco, B. J.
    Viktorovich, P. A.
    Moiseevich, M. G.
    Avila, G. I.
    Munoz, M.
    Saslavsky, M. M.
    Beguelin, G. Z.
    Fogliatto, L.
    Salvino de Araujo, A.
    Pereira, J.
    Rodrigues de Oliveira, J. S.
    Luiz da Silva, R.
    de Mattos, E. R.
    Santi, P. Xavier
    LEUKEMIA & LYMPHOMA, 2019, 60 (14) : 3375 - 3385
  • [35] Rituximab Treatment Strategy for Patients with Diffuse Large B-Cell Lymphoma after First-Line Therapy: A Systematic Review and Meta-Analysis
    Ren, Yuan-Rong
    Jin, Yong-Dong
    Zhang, Zhi-Hui
    Li, Li
    Wu, Ping
    CHINESE MEDICAL JOURNAL, 2015, 128 (03) : 378 - 383
  • [36] Rituximab Treatment Strategy for Patients with Diffuse Large B-Cell Lymphoma after First-Line Therapy: A Systematic Review and Meta-Analysis
    Ren Yuan-Rong
    Jin Yong-Dong
    Zhang Zhi-Hui
    Li Li
    Wu Ping
    中华医学杂志英文版, 2015, 128 (03) : 378 - 383
  • [37] Interim Results From a Phase II Study Of Non-Anthracycline Combination Of Oxaliplatin-Gemcitabine Plus Rituximab (R-GemOx) As First-Line Treatment In Elderly Patients With Diffuse Large B-Cell Lymphoma
    Fan, Lei
    Wang, Li
    Xu, Ji
    Zhang, Run
    Yang, Yuqiong
    Huang, Dongping
    Shen, Yunfeng
    Zhou, Min
    Yu, Liang
    Zhang, Zhihong
    Xu, Wei
    Li, Jianyong
    BLOOD, 2013, 122 (21)
  • [38] Phase II study of Rituximab in combination with Fludarabine in patients (pts) with low-grade or follicular B-cell lymphoma.
    Czuczman, MS
    Fallon, A
    Scarpace, A
    Stewart, C
    Bernstein, ZP
    McCarthy, P
    Skipper, M
    Brown, K
    Miller, K
    Wentling, D
    Rock, MK
    Benyunes, M
    Grillo-Lopez, A
    Bernstein, SH
    BLOOD, 2000, 96 (11) : 729A - 729A
  • [39] Prognostic predictors of newly diagnosed Diffuse large B-cell lymphoma treated with R-THP-COP regimen
    Okano, Yoshiaki
    Oyake, Tatsuo
    Kitamura, Sawako
    Asano, Kazuya
    Sato, Tsuyoshi
    Maeta, Takahiro
    Miyajima, Shinri
    Otsu, Akihiro
    Nishiya, Maki
    Sasaki, Ryousei
    Kowata, Shugo
    Ishida, Yoji
    Ito, Shigeki
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2025, 65 (01) : 49 - 54
  • [40] Zanubrutinib, Polatuzumab Vedotin and Rituximab (ZPR) Combination Regimen for Relapsed/Refractory Patients with Diffuse Large B-Cell Lymphoma
    Zhang, Yian
    Yuan, Ling
    Zhuang, Jingli
    Wang, Zhimei
    Zhang, Xuejiao
    Wang, Weiguang
    Liu, Peng
    BLOOD, 2023, 142
12345